CDXS - Codexis Inc logo

Codexis Inc

CDXS

Codexis, Inc. develops enzyme technologies for therapeutic manufacturing, using its CodeEvolver platform to enhance and commercialize enzymes. Its ECO Synthesis platform enables scalable production of RNAi therapeutics for diverse applications.

โš•๏ธ Healthcare NASDAQ Listed 2010 $ USD
$1,000 invested 10 years ago โ†’$316today

Score Overview

1 Year
Score
Net Growth30.13%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth10.36%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.3
Net Growth-44.38%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth-25.85%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-259.00%
Net Trend50%
Net Income Consistency
Rev Growth59.06%
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth-259.71%
Net Trend44%
Net Income Consistency
Rev Growth-27.47%
Rev Trend75%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Codexis Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available Net Income Consistency rankings on 20 years of fundamentals. CDXS does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-29
$ 1.35โ€”
1 Year2025-09-29
$ 2.46-45.23%
5 Years2021-09-29
$ 23.10-94.16%
10 Years2016-09-29
$ 4.27-68.38%
All Time2010-04-22
$ 13.26-89.82%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 77M-$ 30M$ 54M
2025$ 70M-$ 43M$ 78M
2024$ 59M-$ 65M$ 73M
2023$ 70M-$ 76M$ 65M
2022$ 138M-$ 33M$ 113M
2021$ 104M-$ 21M$ 116M
2020$ 69M-$ 24M$ 150M
2019$ 68M-$ 11M$ 90M
2018$ 60M-$ 10M$ 53M
2017$ 50M-$ 22M$ 31M
2016$ 48M-$ 8M$ 19M
2015$ 41M-$ 7M$ 23M
2014$ 35M-$ 19M$ 26M
2013$ 31M-$ 41M$ 25M
2012$ 88M-$ 30M$ 45M
2011$ 123M-$ 16M$ 53M
IPO2010$ 107M-$ 8M$ 72M
CDXS - Codexis Inc logo

Codexis Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 69M to $ 70M and net income went from -$ 24M to -$ 43M. Revenue increased in 3 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 41M to $ 70M and net income went from -$ 7M to -$ 43M. Revenue increased in 8 of those 10 years; net income in 5.

Codexis Inc currently holds a 5-year HDB Score of 4.3 out of 10. How the HDB Score is calculated.

Membership

Explore CDXS with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,814 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies